110 likes | 249 Views
A spin-off SME from Pharmapolis Innovative Pharmaceutical Cluster Debrecen Biomarker development in the interface of industry and clinics. Tilburg, 9/8/2011. Pharma Cluster Debrecen. Tra diti ons Pharmapolis concept Triple helix Strategic fields Founders – members Cluster life cycle
E N D
A spin-off SME from Pharmapolis Innovative Pharmaceutical Cluster Debrecen Biomarker development in the interface of industry and clinics Tilburg, 9/8/2011
Pharma Cluster Debrecen • Traditions • Pharmapolis concept • Triple helix • Strategic fields • Founders – members • Cluster life cycle • Projects
Project Companies CERORIN Ltd. • Development of preprandial and bedtime oral insulin preparation Pharmatom Ltd. • PET radioligand development for characterization of binding of drugs and drug candidates to HERG channels BioDiagnostica Ltd. • Pulmonary Cancer Diagnosys Development
Who we are? What is UD-GenoMed? • Core facility DCGC • Service provider • for industy • Functional genomics • Several projects to IP portfolio development
History • Sept. 2007 Foundation of UDG • 2008 project planning, proposal writing, services starting • 2009 new projects, new services (Affy workstation) • 2010 capital raising by individuals, EU grants, industry financed R&D projects • 2011 Cell and protein engineering
Services 2 • RT PCR • Consultation • Q PCR Assay • Genotyping qPCR Assay (SNP detection) • Low Density Array (Microfluidics Card) • Agilent Bioanalyzer (RNA Nano Chip, RNA Pico Chip, DNA Chip) • Affymetrix microarray • Sequencingand fragment analysis • NGS
Referenses Collaborating partners Customers Trading partners
Projektek, K+F szerződéses munkák • SCHIZO-08 - Nagy László / Zahuczky Gábor • EPIGEN09+ - Bálint László Bálint • TRANSCOM - Fésüs László • RA, IBS biomarker kutatás – Meskó Bertalan • Globális génexpressziós analízisek – Póliska Szilárd • Ig v régió szekvenálás – Zahuczky Gábor • Preklinikai vizsgálatok – Pap Attila